Gout in primary care

Drug and Therapeutics Bulletin

Volumn 42, Issue 5, 2004, Pages 37-40

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AZAPROPAZONE; CIDOFOVIR; CODEINE; COLCHICINE; CORTICOSTEROID; DICLOFENAC; ETORICOXIB; IBUPROFEN; INDOMETACIN; KETOPROFEN; METHYLPREDNISOLONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PIROXICAM; PLACEBO; PREDNISOLONE; PROBENECID; PURINE; RASBURICASE; SULFINPYRAZONE; SULINDAC; UNINDEXED DRUG; URATE; URIC ACID; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ADULT; AGING; ALCOHOL CONSUMPTION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; DIARRHEA; DIETARY INTAKE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FREQUENCY ANALYSIS; GASTROINTESTINAL HEMORRHAGE; GOUT; HUMAN; HYPERURICEMIA; LIFESTYLE; MONARTHRITIS; MUSCULOSKELETAL DISEASE; NEPHROTOXICITY; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PROPHYLAXIS; REVIEW; RHEUMATIC DISEASE; SEX DIFFERENCE; SIDE EFFECT; UNITED KINGDOM; URIC ACID BLOOD LEVEL; VOMITING; WEIGHT REDUCTION;

EID: 2642512397     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2004.42537     Document Type: Review

References (24)

1. Harris CM et al. The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995; 48: 1153-8.
2. Kim KY et al. A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003; 25: 1593-617.
3. Wallace SL et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900.
4. The management of septic arthritis. DTB 2003; 41: 65-8.
5. Agudelo CA, Wise CM. Crystal-associated arthritis. Clin Geriatr Med 1998; 14: 495-513.
6. Rott KT, Agudelo CA. Gout. JAMA 2003; 289: 2857-60.
7. Campion EW et al. Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. Am J Med 1987; 82: 421-6.
8. Logan JA et al. Serum uric acid in acute gout. Ann Rheum Dis 1997; 56: 696-7.
9. Snaith ML. ABC of rheumatology: gout, hyperuricaemia, and crystal arthritis. BMJ 1995; 310: 521-4.
10. Schumacher HR et al. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ 2002; 324: 1488-92.
11. Rubin BR et al. Efficacy and safety profile of treatment with etoricoxib 120mg once daily compared with indomethacin 50mg three times daily in acute gout. Arthritis Rheum 2004; 50: 598-606.
12. Ahern MJ et al. Does colchicine work? The results of the first controlled study in acute gout. Aust N Z J Med 1987; 17: 301-4.
13. Morris I et al. Colchicine in acute gout. BMJ 2003; 327: 1275-6.
14. Colchicine tablets BP 500mcg. Summary of product characteristics, UK. Celltech Manufacturing Services Ltd, July 2001.
15. Groff GD et al. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum 1990; 19: 329-36.
16. Siegel LB et al. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. J Rheumatol 1994; 21: 1325-7.
17. Fernández C et al. Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide. J Rheumatol 1999; 26: 2285-6.
18. Schlesinger N et al. Local ice therapy during bouts of acute gouty arthritis. J Rheumatol 2002; 29: 331-4.
19. Dessin PH et al. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis 2000; 59: 539-43.
20. Choi HK et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl Med 2004; 350: 1093-103.
21. Choi HK et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363: 1277-81.
22. Dincer HE et al. Asymptomatic hyperuricemia: to treat or not to treat. Cleve Clin J Med 2002; 69: 594-608.
23. Zyloric tablets 100mg, 300mg. Summary of product characteristics, UK. The Wellcome Foundation Ltd UK, June 2002.
24. Anturan tablets 100mg. Summary of product characteristics, UK. Novartis Pharmaceuticals UK Ltd, July 2000.